| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $10.37B | +152.4% |
| R&D Expense | $205.0M | +43.4% |
| SG&A Expense | $1.11B | +18.3% |
| Operating Income | $2.31B | +392.0% |
| Interest Expense | $818.0M | +16.5% |
| Pre-tax Income | $1.77B | +228.0% |
| Income Tax | $344.0M | +123.4% |
| Net Income | $1.22B | -33.4% |
| EPS (Basic) | $1.60 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.11B | -19.1% |
| Accounts Receivable | $484.0M | +81.3% |
| Inventory | $38.0M | +35.7% |
| Current Assets | $5.78B | -14.3% |
| Total Assets | $21.78B | -1.2% |
| Current Liabilities | $4.42B | +13.3% |
| Long-term Debt | $12.13B | -13.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Capital Expenditures | $1.02B | +56.2% |
| -33.3% |
| EPS (Diluted) | $1.60 | -33.3% |
| Total Liabilities |
| $17.67B |
| -3.9% |
| Stockholders' Equity | $4.12B | +6.1% |